CressetCresset creates new Vice President role UK-based CRO Cresset has expanded its senior leadership team with the appointment of Nick Foster as Vice President of their Discovery CRO business. more ➔
Closed Loop MedicineClosed Loop Medicine appoints new COO The appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Companys product and partnership programs. more ➔
Amarna TherapeuticsAmarna Therapeutics appoints new CEO Leiden-based Amarna Therapeutics announces the appointment of Dr Henk Streefkerk as the company’s new Chief Executive Officer and Medical Director. Streefkerk has already been Amarna’s Medical Director … more ➔
Immunovia ABImmunovia AB with new CEO Jeff Borcherding, President of Immunovia’s US subsidiary since April 2022, has been the new Global CEO of Sweden’s Immunovia AB since the end of April. more ➔
AbivaxChanges in the management of Abivax The French Abivax SA has had a new CEO since the beginning of May. Marc de Garidel took over the position and became interim chairman of the supervisory board. more ➔
ImmunOs TherapeuticsImmunology expert joins ImmunOs Therapeuti... The biopharmaceutical company ImmunOs Therapeutics AG has appointed Michael A. Curran, PhD, as Chairman of the Company´s Scientific Advisory Board. more ➔
ingenzaIngenza appoints Steve Jones as new CFO Steve Jones took over the role of Chief Financial Officer (CFO) at the biotech company Ingenza Ltd (UK) at the beginning of April. He brings many years of experience and expertise in finance, having … more ➔
Neogap Therapeutics ABNeogap Therapeutics appoints CMOSwedish Neogap Therapeutics got a new Chief Medical Officer (CMO). Dr Hanjing Xie has recently started her new position at the Stockholm-based biotech company. more ➔
Bayer AGBayer AG presents successor für CEO Bauma...The Supervisory Board of Bayer AG has appointed Roche Pharmaceuticals CEO Bill Anderson (56) as new Chairman of the Management Board of Bayer AG with effect from 1 June 2023. more ➔
Oxford BiomedicaOxford Biomedica changes management Former Rentschler-CEO Dr Frank Mathias officially takes up his new position as CEO and board member of Oxford Biomedica at the end of March. more ➔
